

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 1, 26 | Noseworthy John H | director | A-Award | 240 | — |
Daily · Wilder smoothing
| Oct 1, 26 |
| Montgomery Rice Valerie Md |
| director |
| A-Award |
| 257 |
| — |
| Oct 1, 26 | Mcnabb Frederick William Iii | director | A-Award | 291 | — |
| Oct 1, 26 | Gottlieb Scott | director | A-Award | 257 | — |
| Oct 1, 26 | Gil Kristen | director | A-Award | 240 | — |
| Oct 1, 26 | Garcia Paul R | director | A-Award | 103 | — |
| Oct 1, 26 | Garcia Paul R | director | A-Award | 155 | — |
| Oct 1, 26 | Flynn Timothy Patrick | director | A-Award | 262 | — |
Classic floor pivots from 2026-10-21
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 69.65 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 90.84 | Oscillator | Sell |
| Williams %R (14) | -8.18 | Oscillator | Sell |
| MACD (12, 26, 9) | 7.29 (Hist 5.49) | Oscillator | Strong Buy |
| Average Directional Index (14) | 32.68 (+DI 32.3 / -DI 10.6) | Trend | Strong Buy |
| EMA 20 | 391.86 | MA | Strong Buy |
| SMA 20 | 384.67 | MA | Strong Buy |
| EMA 50 | 390.29 | MA | Strong Buy |
| SMA 50 | 387.81 | MA | Strong Buy |
| SMA 200 | 360.28 | MA | Strong Buy |
Stock news · updated daily
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
One of SCHD's top four holdings is paying out nearly everything it earns as a dividend, and retirees need to know whether that payout is a ticking clock or a sign of strength before they count on it for income.
I'm initiating coverage of UnitedHealth Group with a Strong Buy rating and a $533 price target, implying 33% upside potential. I believe UNH margin recovery, Optum Health's shift toward higher-quality contracts, and AI-driven operating efficiencies can support double-digit EPS growth through 2028. UNH trades at a forward non-GAAP PEG ratio of 1.38x, approximately 26% below the healthcare sector median of 1.87x.
Partnership Will Transform How Clinical Development is Designed and Executed MORRISVILLE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Syneos Health® today announced a partnership with Optum to build a more adaptive and connected model for clinical development, helping biopharmaceutical companies deliver promising therapies to patients sooner.
On CNBC's “Halftime Report Final Trades,” Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, picked UnitedHealth Group Incorporated (NYSE:UNH) following strong quarterly results.
Maia Wealth LLC raised its holdings in UnitedHealth Group Incorporated (NYSE: UNH) by 17.7% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 14,252 shares of the healthcare conglomerate's stock after purchasing an additional 2,148 shares during the quarter. Maia Wealth
Rate and energy headlines have kept the broad market jumpy, yet one sector keeps finding buyers. Healthcare has led on days when the S&P 500 slipped, and the Nasdaq Biotechnology Index has pushed to record highs.
More than 4.6 million Americans left the individual health insurance market in a single year. New research from KFF shows enrollment fell 18%, from 25.2 million in June 2025 to 20.5 million in June 2026.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Oct 13, 2026 | 4.14 | 4.69 | Beat 13.3% | $112.7B |
| Jul 16, 2026 | 4.91 | 6.38 | Beat 29.9% | $112.0B |
| Apr 21, 2026 | 6.58 | 7.23 | Beat 9.9% | $111.7B |
| Jan 27, 2026 | 2.10 | 2.11 | Beat 0.5% | $113.2B |
| Oct 28, 2025 | 2.80 | 2.92 | Beat 4.3% | $113.2B |
| Jul 29, 2025 | 4.45 | 4.08 | Miss -8.3% | $111.6B |
TTM vs. 5-year historical average (annual ratios)
| Metric | UNH | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 23.8x | 26.3x · sector 20.7x | Elevated |
| Forward P/E (FY26E) | 20.3x | EPS est. 20.56 | In line |
| Price / Book | 3.6x | 5.4x | Discount |
| Price / Sales | 0.8x | 1.3x | Discount |
| EV / EBITDA | 15.1x | 16.8x | In line |
| Return on equity | 16.1% | — | Healthy |
| Gross margin | 22.8% | 22.8% | In line |
| Debt / Equity | 0.71 | 0.76 | Moderate |
| Piotroski / Altman Z | 8/9 | Z 2.66 | Grey zone |
Discounted cash flow model
FY2025 · 10-K disclosure
Current price $417.15
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| 4 | Oct 5, 2026 | 2026-10-05 16:25:07 | View |
| 4 | Oct 5, 2026 | 2026-10-05 16:22:50 | View |
| 4 | Oct 5, 2026 | 2026-10-05 16:21:52 | View |
| 4 | Oct 5, 2026 | 2026-10-05 16:21:22 | View |
| 4 | Oct 5, 2026 | 2026-10-05 16:17:29 | View |
| 4 | Sep 24, 2026 | 2026-09-24 16:13:47 | View |
Proxy statement (DEF 14A) disclosures
| Executive | Salary | Stock | Total |
|---|---|---|---|
| Stephen Hemsley Chief Executive Officer | $596.2K | $0 | $60.94M |
| Andrew Witty Former Chief Executive Officer | $903.8K | $17.25M | $24.60M |
| John Rex Former President and Chief Financial Officer | $1.40M | $11.25M | $24.48M |
| Timothy Noel Chief Executive Officer, UnitedHealthcare | $981.8K | $15.00M | $20.20M |
| Patrick Conway, M.D. Chief Executive Officer, Optum | $980.6K | $15.00M | $19.92M |
| Christopher Zaetta Executive Vice President Chief Legal Officer and Corporate Secretary | $845.2K | $12.25M | $15.79M |
| Oct 20, 26 |
| RBC Capital |
| maintain |
| Outperform |
| Outperform |
| Oct 16, 26 | Bernstein | maintain | Outperform | Outperform |
| Oct 16, 26 | JP Morgan | maintain | Overweight | Overweight |
| Oct 15, 26 | TD Cowen | maintain | Hold | Hold |
| Oct 14, 26 | Barclays | maintain | Overweight | Overweight |
| Oct 14, 26 | Piper Sandler | maintain | Overweight | Overweight |
| Oct 14, 26 | Baird | maintain | Neutral | Neutral |
| Oct 9, 26 | TD Cowen | maintain | Hold | Hold |
| Jul 21, 26 | Mizuho | maintain | Outperform | Outperform |